Showing results (171-180 of 305) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patientsAntonio Palumbo, Francesca Gay, Patrizia Falco, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 30, 2015
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic LeukemiaLuisa Giaccone, Ernesta Audisio, Benedetto Bruno, et al.
JCO Clinical Cancer Informatics|October 22, 2019
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical OutcomesGian Maria Zaccaria, Simone Ferrero, Samanta Rosati, et al.
Ejhaem|June 19, 2024
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in ItalyFrancesca Fazio, Maria Teresa Petrucci, Laura Corvatta, et al.
Blood|June 19, 2013
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated resultsFrancesca Gay, Valeria Magarotto, Claudia Crippa, et al.
Haematologica|March 24, 2018
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemiaDaniela Drandi, Elisa Genuardi, Irene Dogliotti, et al.
Experimental Hematology|December 13, 2006
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populationsMarco Ladetto, Barbara Mantoan, Federica De Marco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Survival and years of life lost in different age cohorts of patients with multiple myelomaHeinz Ludwig, Vanessa Bolejack, John Crowley, et al.
European Journal of Haematology|November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian expertsFrancesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.
Blood|August 24, 2007
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclastsSonia Vallet, Noopur Raje, Kenji Ishitsuka, et al.
Pageof 31